Evidence map›Paper›PMID 34737893›Full record

ArticleFuture science OA2021

Does perioperative systemic therapy represent the optimal therapeutic paradigm in organ-confined, muscle-invasive urothelial carcinoma?

Luca Scafuri, Antonella Sciarra, Felice Crocetto, Matteo Ferro, Carlo Buonerba, Francesco Ugliano, Germano Guerra, Roberto Sanseverino, Giuseppe Di Lorenzo

Open access · goldAbstract readEditorial
In one paragraph

Article in Future science OA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Luca ScafuriOncology Unit, Hospital 'Andrea Tortora,' ASL Salerno, Pagani, 84016, Italy.
Antonella SciarraDepartment of Experimental Medicine, University of Campania 'Luigi Vanvitelli,' Naples, NA, 80131, Italy.
Felice CrocettoDepartment of Neurosciences, Reproductive Sciences & Odontostomatology, Federico II University, Naples, 80131, Italy.
Matteo FerroDivision of Urology, European Institute of Oncology (IEO), IRCCS, Milan, 20099, Italy.
Carlo BuonerbaOncology Unit, Hospital 'Andrea Tortora,' ASL Salerno, Pagani, 84016, Italy.
Francesco UglianoDepartment of Medicine & Health Science, University of Molise, Campobasso, 86100, Italy.
Germano GuerraDepartment of Medicine & Health Science, University of Molise, Campobasso, 86100, Italy.
Roberto SanseverinoDepartment of Urology, Umberto I Hospital, ASL Salerno, Nocera Inferiore, 84014, Italy.
Giuseppe Di LorenzoOncology Unit, Hospital 'Andrea Tortora,' ASL Salerno, Pagani, 84016, Italy.
CTO Andrea Alesini · ITUniversity of Molise · ITEuropean Institute of Oncology · ITFederico II University Hospital · ITOspedali Riuniti Umberto I · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant therapybladder cancerneoadjuvant therapy

Identifiers

PMID34737893
PMCPMC8558855
OpenAlexW3208153007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.